Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Redpoint Ventures IV, LLC | CYN Cyngn Inc. | 13G/A | 3.6% | Dec 31, 2023 | 2y |
| EVENTIDE ASSET MANAGEMENT, LLC | ANNX Annexon, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | MOTS Motus GI Holdings, Inc. Common Stock | 13G | 9.99% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | APVO Aptevo Therapeutics Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| Granahan Investment Management, LLC | MASS 908 Devices Inc. | 13G | 6.3% | Dec 31, 2023 | 2y |
| Logos Global Management LP | SYRE Spyre Therapeutics, Inc. | 13G/A | 0.4% | Dec 31, 2023 | 2y |
| BOXER CAPITAL, LLC | PMVP PMV Pharmaceuticals, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | MRTX Mirati Therapeutics, Inc. Common Stock | 13G/A | 0.71% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | VAQC Vector Acquisition Corporation II Class A Ordinary Shares | 13G/A | 0.08% | Dec 31, 2023 | 2y |
| Centiva Capital, LP | DMYY dMY Squared Technology Group, Inc. | 13G/A | 3.15% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | FDMT 4D Molecular Therapeutics, Inc. | 13G/A | 5.34% | Dec 31, 2023 | 2y |
| EARNEST PARTNERS LLC | UFCS United Fire Group Inc | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| Atalaya Capital Management LP | CCAI Cascadia Acquisition Corp. Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Xylo Technologies Ltd. | PRZO ParaZero Technologies Ltd. | 13G | 20.04% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | KRNY Kearny Financial Corp. | 13G | 10% | Dec 31, 2023 | 2y |
| Exor N.V. | VEON VEON Ltd. | 13G/A | 7.6% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | INZY Inozyme Pharma, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | IE Ivanhoe Electric Inc. | 13G | 6.4% | Dec 31, 2023 | 2y |
| Anson Funds Management LP | ZVSA ZyVersa Therapeutics, Inc. | 13G | 9.8% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | BDTX Black Diamond Therapeutics, Inc. | 13G | 7.6% | Dec 31, 2023 | 2y |
| D1 Capital Partners L.P. | LXEO Lexeo Therapeutics, Inc. | 13G | 9.4% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | INTE Integral Acquisition Corporation 1 Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Commodore Capital LP | IMUX Immunic, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | CRGX CARGO Therapeutics, Inc. Common Stock | 13G | 5.4% | Dec 31, 2023 | 2y |
| Andrew Stranberg | SWAG Stran & Company, Inc. | 13G/A | 28.7% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | NAPA The Duckhorn Portfolio, Inc. | 13G/A | 7.3% | Dec 31, 2023 | 2y |
| Dragoneer Investment Group, LLC | CCC CCC Intelligent Solutions Holdings Inc. | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| Johan Wedell-Wedellsborg | YMAB Y-mAbs Therapeutics, Inc. Common Stock | 13G/A | 10.7% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | BLUA BlueRiver Acquisition Corp. | 13G/A | 9.75% | Dec 31, 2023 | 2y |
| TENOR CAPITAL MANAGEMENT Co., L.P. | BYNO byNordic Acquisition Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| Lundbeckfond Invest A/S | LXEO Lexeo Therapeutics, Inc. | 13G | 6.9% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | RGNX REGENXBIO Inc. | 13G/A | 8.6% | Dec 31, 2023 | 2y |
| Forager Fund, L.P. | RM Regional Management Corp. | 13G/A | 10% | Dec 31, 2023 | 2y |
| Neeraj Agrawal | CXM Sprinklr, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Matthew P. Sheehy | BAER Bridger Aerospace Group Holdings, Inc. | 13G | 22.2% | Dec 31, 2023 | 2y |
| Jeff Lawson | TWLO Twilio Inc | 13G/A | 3.8% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | RVTY Revvity, Inc. | 13G/A | 9.1% | Dec 31, 2023 | 2y |
| Cheshire MD Holdings, LLC | MIRO Miromatrix Medical Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| COHEN & STEERS, INC. | CUZ Cousins Properties Inc | 13G/A | 0% | Dec 31, 2023 | 2y |
| Stier Jennifer | ANGI Angi Inc. | 13G/A | 2.9% | Dec 31, 2023 | 2y |
| Michael Klein | SKIL Skillsoft Corp. | 13G/A | 12% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | DRMA Dermata Therapeutics, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| Empyrean Capital Partners, LP | CHAA Catcha Investment Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | BCSA Blockchain Coinvestors Acquisition Corp. I Class A Ordinary Shares | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | ENOV Enovis CORP | 13G/A | 12.1% | Dec 31, 2023 | 2y |
| WHITEBOX ADVISORS LLC | ELBM Electra Battery Materials Corp | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Advent International, L.P. | FWRG First Watch Restaurant Group, Inc. | 13G/A | 57% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | BRKR Bruker Corp | 13G/A | 9.5% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | ABOS Acumen Pharmaceuticals, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Alison F. Geballe | LEVI Levi Strauss & Co | 13G/A | 4.6% | Dec 31, 2023 | 2y |